Orphai Therapeutics, LLC, a limited liability company organized in Delaware, applied to register the trademark IRULYA THERAPEUTICS with the United States Patent and Trademark Office on 2026-07-10, serial number 99933773. The application covers 4 classes of goods and services, Class 5 (Pharmaceuticals and supplements); Class 10 (Medical devices); Class 42 (Software as a service and technology services); Class 44 (Medical and beauty services), and is based on an intent to use the mark in commerce (the goods or services are not yet sold under it). The latest step on the record is "Application filing receipt mailed" on 2026-07-10.
| Mark | IRULYA THERAPEUTICS |
|---|---|
| Applicant | Orphai Therapeutics, LLC, a limited liability company organized in Delaware |
| Applicant's location | New Haven, Delaware |
| Serial number | 99933773 |
| Filed | 2026-07-10 |
| Filing basis | An intent to use the mark in commerce (the goods or services are not yet sold under it) |
| Classes | Class 5 (Pharmaceuticals and supplements); Class 10 (Medical devices); Class 42 (Software as a service and technology services); Class 44 (Medical and beauty services) |
| Latest step on the record | Application filing receipt mailed, 2026-07-10 |
Want the whole picture on Orphai Therapeutics, LLC?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Orphai Therapeutics, LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Orphai Therapeutics, LLC covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
What IRULYA THERAPEUTICS will be used for
Class 5 (Pharmaceuticals and supplements)
Pharmaceutical preparations for the treatment and prevention of pulmonary, oncology, and neurology diseases and disorders; drug delivery agents in the form of tablets, capsules, oral dissolving tablets, oral disintegrating tablets, injectables, inhalation or nasal formulations, and associated drug-device combinations thereof that facilitate the delivery of pharmaceutical preparations; Inhalers filled with pharmaceutical preparations for the treatment of pulmonary diseases; syringes sold filled with pulmonary, oncology, and neurology pharmaceuticals
Class 10 (Medical devices)
Drug delivery devices sold empty, namely, dry powder inhalers, metered dose inhalers, Nebulizers, and Soft mist devices, and parts and components therefor; Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Instruments and apparatus provided empty used for the inhalation of pharmaceuticals; Nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of pulmonary diseases; Nebulizers for medical purposes; Disposable syringes; medical syringes; Syringes for medical purposes and for injections; Syringes for injections; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical apparatus for the treatment of respiratory conditions
Class 42 (Software as a service and technology services)
Medical research; pharmaceutical research and development; scientific research and development; medical and scientific research in the field of pulmonary, oncology, and neurology diseases and disorders; testing of pharmaceuticals; pharmaceutical products development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; development of pharmaceutical preparations and medicines; medical and scientific research in the field of pharmaceuticals; Laboratory research in the field of pharmaceuticals; Product design and development in the field of dry powder inhaler devices and drug delivery systems; providing medical research information in the field of pharmaceuticals
Class 44 (Medical and beauty services)
Providing medical information; medical services; providing medical information in the field of pulmonary, oncology, and neurology diseases and disorders; providing medical information, consultancy and advisory services
Where the application stands
| Date | Step on the record |
|---|---|
| 2026-07-10 | New application entered |
| 2026-07-10 | Application filing receipt mailed |
Other new marks from Orphai Therapeutics, LLC
| Filed | Mark | Classes |
|---|---|---|
| 2026-08-13 | IR | 5, 10, 42, 44 |
| 2026-08-13 | IRULYATX | 5, 10, 42, 44 |
| 2026-08-04 | IRULYATX | 5, 10, 42, 44 |
| 2026-08-04 | IR | 5, 10, 42, 44 |
| 2026-07-24 | IRULYATX | 5, 10, 42, 44 |
| 2026-07-10 | IRULYA | 5, 10, 42, 44 |
MentionFox follows a brand's mentions across social platforms, news, forums and reviews. Sign up and IRULYA THERAPEUTICS is already filled in as the brand to track.
Monitor mentions of IRULYA THERAPEUTICSGetFoxChat puts an AI chat operator on your website that answers visitors from your own pages. Check your site to see what it would answer.
Check your site with GetFoxChatWho runs it, who owns it, where the money comes from and what to watch for, every claim linked to its source.
Order Full Report on Orphai Therapeutics, LLCWhere this comes from
A company that wants to protect a new brand name in the United States files a trademark application with the United States Patent and Trademark Office. The application names the mark, the company applying, the classes of goods and services it will be used for, in the company's own words, and whether the brand is already on sale or is still to launch. Each application gets a serial number and a public record that follows it through examination.
Every fact on this page is taken from that record and linked to it. MentionFox lists applications by companies only, corporations and limited liability companies; applications filed by individuals are not listed. A filing shows a company's plans for a name; it does not show sales, and an application can still be refused or abandoned.
Source: USPTO record for IRULYA THERAPEUTICS, serial number 99933773.